Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071396
Status:
COMPLETED
Last Update Posted:
2012-08-07
First Post:
2003-10-21
Brief Title:
Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-10
Start Date Type:
None
Primary Completion Date:
2006-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-08
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-21
First Submit QC Date:
October 21 2003
Study First Post Date:
2003-10-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-02-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-01
Last Update Post Date:
2012-08-07
Last Update Post Date Type:
ESTIMATED